Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 365

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1B
Chunk 365
---
, with regard to any trading in our own securities, it is our policy to comply with the federal
securities laws and the applicable exchange listing requirements.

Committees
of the Board

Our
Board has established four standing committees—Audit, Compensation, Nominating, and Science and Technology. Each of Audit, Compensation
and Nominating Committee operates under a written charter that has been approved by our Board.

The
members of each of the Board committees and committee Chairpersons are set forth in the following chart.

    Name
     
    Audit
     
    Compensation
     
    Nominating
     
    Science and
    Technology

    Mark J. Gilbert, M.D.

    X

    William B. Hayes
     
    Chairperson
     
    X

    Hila Karah
     
    X

    Chairperson

    Anthony J. Maddaluna

    Chairperson
     
    X
     
    X

    Robert E. Martell, M.D., Ph.D.
     
    X

    X

    Michael J. Newman, Ph.D.

    Chairperson

77

Audit
Committee

Our
Audit Committee’s responsibilities include:

    ●
    appointing,
    approving the compensation of, and assessing the independence of our independent registered public accounting firm;

    ●
    monitoring the rotation
    of the partners of our independent registered public accounting firm on our audit engagement team and considering periodically the
    rotation of auditing firms;

    ●
    overseeing the work of
    our independent registered public accounting firm;

    ●
    reviewing and discussing
    with management and the independent registered public accounting firm the results of the annual audit, including our annual financial
    statements and related disclosures, and the results of the review by the independent registered public accounting firm of our quarterly
    financial statements and related disclosures;

    ●
    discussing with management
    and the independent registered public accounting firm the adequacy of our internal control over financial reporting, disclosure controls
    and procedures, compliance with legal and regulatory requirements, and code of business conduct and ethics;

    ●
    discussing with management
    and the independent registered public accounting firm our risk management policies;

    ●
    establishing policies regarding
    hiring employees from the independent registered public accounting firm and procedures for the receipt and retention of accounting
    related complaints and concerns;

    ●
    meeting independently with
    our